Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion
Top Cited Papers
- 1 November 2013
- journal article
- practice guideline
- Published by Elsevier in Fertility and Sterility
- Vol. 100 (5), 1224-1231
- https://doi.org/10.1016/j.fertnstert.2013.08.041
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Meta-Analysis on the Possible Association Between In Vitro Fertilization and Cancer RiskInternational Journal of Gynecologic Cancer, 2013
- Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysisFertility and Sterility, 2011
- No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study GroupAnnals of Oncology, 2010
- GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical dataHuman Reproduction Update, 2008
- RETRACTED: Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized studyFertility and Sterility, 2008
- Gonadotropin-releasing hormone analogs in fertility preservation-lack of biological basis?Nature Clinical Practice Endocrinology & Metabolism, 2008
- Are Children Born After Assisted Reproductive Technology at Increased Risk for Adverse Health Outcomes?Obstetrics & Gynecology, 2004
- Late reproductive sequelae following treatment of childhood cancer andoptions for fertility preservationBest Practice & Research Clinical Endocrinology & Metabolism, 2002
- Radiation damage to the uterus — Review of the effects of treatment of childhood cancerHuman Fertility, 2002
- Personal practice: Fertility preservation for children treated for cancer (1): scientific advances and research dilemmasArchives of Disease in Childhood, 2001